Hydrogels, Nanocin Technology and Novel Injectable Formulation Discussed at Controlled Release Delivery 2017

22:00 EST 7 Mar 2017 |

London, United Kingdom, March 08, 2017 --( The 14th annual conference will gather drug development experts and formulation specialists to explore the latest innovations made within the industry. Topics which will be discussed include: lipid suspension, novel injectable formulations, controlled erosion, parenteral and oral controlled release strategies, parenteral delivery, nanocin technology, nanomedicine and so much more.

Hydrogels and nanocin technology will be hot topics discussed throughout the two day program.

Patrick Garidel, Associate Director of Protein Science from Boehringer Ingelheim will provide a presentation on day two of the conference on ‘Hydrogel formulations for biologics’ where he will discuss and provide case studies on:

• Rational for sustained release formulations for biologics
• Influence of gel network properties on release kinetics
• Impact of molecular format on release kinetics
• Drug-delivery system compatibility

Liam Good, Director of Tecrea Ltd will present on day one on ‘Delivery and release of small molecules and biologics using nanocin technology’. Liam will provide an overview of nanocin technology, discuss the mechanisms of nancoin-medicated cell entry and release as well as provide examples of small molecule and biologics delivery and collaborative projects.

Joining Boehringer Ingelheim and Tecrea Ltd include Janssen, GSK, Novartis Institutes for BioMedical Research, Evonik Nutrition and Care, Nanomerics, Ascendia Pharmaceuticals, Nanomerics, InnoCore Pharmaceuticals, NEUWAY Pharma and many more…

A full speaker line-up and detailed conference agenda is available to download online at

Controlled Release Delivery
Strengthening innovation and overcoming the challenging regulatory landscape
3rd & 4th April 2017
London, UK
Sponsored by: Avanti Polar Lipids, Buchi, Data Detection Technologies, Precision NanoSystems and Sirius Analytical

Contact Information:
For all media enquiries contact Zoe Gale on Tel: +44 (0)20 7827 6032 / Email:

To register for the conference, visit or contact Ameenah Begum for group bookings on Tel: +44 (0)20 7827 6166 / Email:

To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email:

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

Contact Information:
SMi Group
Zoe Gale
+44 (0)20 7827 6132
Contact via Email

Read the full story here:

Press Release Distributed by

Original Article: Hydrogels, Nanocin Technology and Novel Injectable Formulation Discussed at Controlled Release Delivery 2017


More From BioPortfolio on "Hydrogels, Nanocin Technology and Novel Injectable Formulation Discussed at Controlled Release Delivery 2017"

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...